Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06472388 |
| Title | Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors (EVENET) |
| Acronym | EVENET |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | AC Camargo Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior | child |
| Covered Countries | BRA |